1. Home
  2. SRBK vs PSNL Comparison

SRBK vs PSNL Comparison

Compare SRBK & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRBK
  • PSNL
  • Stock Information
  • Founded
  • SRBK 1887
  • PSNL 2011
  • Country
  • SRBK United States
  • PSNL United States
  • Employees
  • SRBK N/A
  • PSNL N/A
  • Industry
  • SRBK
  • PSNL Medical Specialities
  • Sector
  • SRBK
  • PSNL Health Care
  • Exchange
  • SRBK Nasdaq
  • PSNL Nasdaq
  • Market Cap
  • SRBK 96.1M
  • PSNL 321.1M
  • IPO Year
  • SRBK N/A
  • PSNL 2019
  • Fundamental
  • Price
  • SRBK $10.67
  • PSNL $5.19
  • Analyst Decision
  • SRBK
  • PSNL Strong Buy
  • Analyst Count
  • SRBK 0
  • PSNL 4
  • Target Price
  • SRBK N/A
  • PSNL $6.81
  • AVG Volume (30 Days)
  • SRBK 20.6K
  • PSNL 439.4K
  • Earning Date
  • SRBK 01-01-0001
  • PSNL 11-06-2024
  • Dividend Yield
  • SRBK N/A
  • PSNL N/A
  • EPS Growth
  • SRBK N/A
  • PSNL N/A
  • EPS
  • SRBK N/A
  • PSNL N/A
  • Revenue
  • SRBK $22,814,000.00
  • PSNL $80,027,000.00
  • Revenue This Year
  • SRBK N/A
  • PSNL $10.85
  • Revenue Next Year
  • SRBK N/A
  • PSNL $8.77
  • P/E Ratio
  • SRBK N/A
  • PSNL N/A
  • Revenue Growth
  • SRBK 52.54
  • PSNL 19.20
  • 52 Week Low
  • SRBK $8.01
  • PSNL $0.89
  • 52 Week High
  • SRBK $11.24
  • PSNL $7.20
  • Technical
  • Relative Strength Index (RSI)
  • SRBK 51.76
  • PSNL 56.29
  • Support Level
  • SRBK $10.97
  • PSNL $4.54
  • Resistance Level
  • SRBK $11.09
  • PSNL $5.35
  • Average True Range (ATR)
  • SRBK 0.06
  • PSNL 0.30
  • MACD
  • SRBK -0.05
  • PSNL 0.05
  • Stochastic Oscillator
  • SRBK 5.50
  • PSNL 84.71

About SRBK SR Bancorp Inc. Common stock

SR Bancorp Inc principal business is to acquire deposits from individuals and businesses in the communities surrounding offices and to use these deposits to fund loans.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: